| Gene symbol | COLEC10 | Synonyms | 3MC3, CL-10, CL-34, CLL1 | Type of gene | protein-coding | |
| Chromosome | 8 | Map location | 8q24.12 | dbXrefs | Entrez:10584 MIM:607620 HGNC:HGNC:2220 Ensembl:ENSG00000184374 AllianceGenome:HGNC:2220 | |
| Description | collectin subfamily member 10 | |||||
| GTO ID | GTC3660 |
| Trial ID | NCT06128044 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CLL1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CB-012 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase 1, Multicenter, Open-Label Study of CB-012, a CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia |
| Year | 2024 |
| Country | United States |
| Company sponsor | Caribou Biosciences, Inc. |
| Other ID(s) | CB12A |
| Cohort 1 | |||||||||||
|
|||||||||||